BCPC (Balchem) EPS without NRI: $5.26 (TTM As of Mar. 2026)


BCPC Balchem Corp BCPC
94 GF Score
Price $171.20
GF Value $177.10
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Balchem EPS without NRI?

Balchem BCPC +1.27% 94 EPS without NRI is $5.26 as of Mar. 2026. GuruFocus rates BCPC with a GF Score™ of 94/100 and a GF Value™ of $177.10 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,257 Chemicals companies, Balchem ranks better than 64.52% on this metric.

Balchem's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $1.33. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $5.26.

During the past 12 months, Balchem's average earnings per share (NRI) Growth Rate was 15.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 8.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 8.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Balchem's EPS without NRI or its related term are showing as below:

BCPC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0   Med: 14.3   Max: 67.7
Current: 8.5

During the past 13 years, Balchem's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 67.70% per year. The lowest was 0.00% per year. And the median was 14.30% per year.

BCPC's 3-Year EPS without NRI Growth Rate is ranked better than
64.52% of 1257 companies
in the Chemicals industry
Industry Median: -1.7 vs BCPC: 8.50

Balchem's EPS (Diluted) for the three months ended in Mar. 2026 was $1.25. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.87.

Balchem's EPS (Basic) for the three months ended in Mar. 2026 was $1.26. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.91.


Balchem  (NAS:BCPC) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Balchem EPS without NRI Related Terms


Balchem EPS without NRI Historical Data

* Premium members only.

The historical data trend for Balchem's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balchem EPS without NRI Chart

Balchem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.57 4.03 4.00 4.37 5.15

Balchem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.22 1.27 1.35 1.31 1.33

BCPC vs SXT, PRM, CBT: EPS without NRI Comparison

For the Specialty Chemicals subindustry, Balchem's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Balchem PE Ratio without NRI vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balchem's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Balchem's PE Ratio without NRI falls into.


BCPC
94GF Score
Balchem Corp BCPC
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balchem EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $5.26 mean?
Balchem (BCPC) has a EPS without NRI of $5.26 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Balchem and its competitors. According to the industry distribution chart, Balchem ranks #446 out of 1257 companies in the Chemicals industry, placing it in the top 35.5%.
Is Balchem's EPS without NRI too high?
Balchem's current EPS without NRI is $5.26. Based on the distribution chart, Balchem ranks #446 out of 1257 companies in the Chemicals industry, which is above the industry midpoint. Overall, Balchem has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's EPS without NRI compare to SXT and PRM?
According to the Chemicals industry distribution chart, Balchem ranks #446 out of 1257 companies for EPS without NRI. This puts Balchem in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Chemicals company?
A good EPS without NRI depends on the Chemicals industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Balchem and its competitors. Balchem's current EPS without NRI is $5.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (BCPC) is currently considered Fairly Valued. The stock's GF Value™ is $177.10, compared to a current price of $171.20 — trading 3.3% below its estimated fair value. The current EPS without NRI is $5.26. Balchem's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Balchem (BCPC), the current EPS without NRI is $5.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Balchem (BCPC) Overvalued in 2026?

Based on GuruFocus' analysis, Balchem stock appears to be undervalued. The current stock price of $171.20 is trading 3.3% below its estimated GF Value™ of $177.10. GuruFocus considers Balchem to be Fairly Valued.

Key valuation signals for BCPC:

  • EPS without NRI: $5.26
  • GF Value™: $177.10 vs. price of $171.20 (3.3% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the BCPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Balchem Business Description

Other Exchanges BL9B:Germany
Address 5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
94GF Score

Get the complete analysis for BCPC

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$171.20
Price
$177.10
GF Value